Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy.
Miller
J W
JW
Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Harvard Medical School, Boston, USA.
Adamis
A P
AP
Aiello
L P
LP
D000818:Animals; D003930:Diabetic Retinopathy / Q000473:pathology / Q000503:physiopathology*; D016228:Endothelial Growth Factors / Q000502:physiology*; D016222:Fibroblast Growth Factor 2 / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000502:physiology; D008222:Lymphokines / Q000502:physiology*; D009389:Neovascularization, Pathologic; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016222:Fibroblast Growth Factor 2; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II